PEORIA â In a historic moment, health care workers in Chicago and Peoria on Tuesday became the first groups in Illinois to receive a COVID-19 vaccine, marking what Illinois Department of Public Health Director Dr. Ngozi Ezike called âthe beginning of the endâ of the pandemic.
The vaccine, developed by the drug companies Pfizer and BioNTech, was granted Emergency Use Authorization by the U.S. Food and Drug Administration last week and is now being shipped throughout the United States. Early studies have shown that after two doses that are given 21 days apart, the vaccine is 95% effective in preventing the disease.
Despite virus vaccine, full reopening of state remains months away
Greg Bishop The Center Square, David C.L. Bauer, dbauer@myjournalcourier.com
Dec. 16, 2020
FacebookTwitterEmail
Dr. Marina Del Rios of University of Illinois Hospital & Health Sciences System receives one of the first COVID-19 vaccinations from Dr. Nikhila Juvvadi on Tuesday.Jose M. Osorio | Chicago Tribune (AP)
Tuesday marked the beginning of a process to move Illinois toward reopening entirely, Gov. J.B. Pritzker said, but a full reopening isn’t likely for months.
After four health care workers in the Peoria area took the first of two doses of the Pfizer COVID-19 vaccine that were delivered Monday, Pritzker said the state is closer to entering the final phase of his COVID-19 reopening plan with no restrictions on business or gathering sizes.
Despite virus vaccine, full reopening of state remains months away - The Edwardsville Intelligencer theintelligencer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theintelligencer.com Daily Mail and Mail on Sunday newspapers.
PEORIA â In a historic moment, health care workers in Chicago and Peoria on Tuesday became the first groups in Illinois to receive a COVID-19 vaccine, marking what Illinois Department of Public Health Director Dr. Ngozi Ezike called âthe beginning of the endâ of the pandemic.
The vaccine, developed by the drug companies Pfizer and BioNTech, was granted Emergency Use Authorization by the U.S. Food and Drug Administration last week and is now being shipped throughout the United States. Early studies have shown that after two doses that are given 21 days apart, the vaccine is 95% effective in preventing the disease.